Lead party: Cairo Angels (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Nawah Scientific Inc. (private company) · Sector: Healthcare, Biotechnology, Pharmaceuticals · Countries of operation: Egypt
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Fund: Cairo Angels Syndicate Fund
Lead investor/buyer: Cairo Angels · Investors/buyers: Cairo Angels
Legal advisers: not identified in the source record.
Source: announced 2 February 2022. Original announcement: wamda.com.


